A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers
Open Access
- 3 July 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (27) , eaba5031
Abstract
Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to less than 10% for most species. In addition, devils are affected by two of the three known transmissible cancers in mammals. Immune checkpoint immunotherapy has transformed human medicine, but a lack of species-specific reagents has limited checkpoint immunology in most species. We developed a cut-and-paste reagent development system and used the fluorescent fusion protein system to show that immune checkpoint interactions are conserved across 160,000,000 years of evolution, CD200 is highly expressed on transmissible tumor cells, and coexpression of CD200R1 can block CD200 surface expression. The system’s versatility across species was demonstrated by fusing a fluorescent reporter to a camelid-derived nanobody that binds human programmed death ligand 1. The evolutionarily conserved pathways suggest that naturally occurring cancers in devils and other species can be used to advance our understanding of cancer and immunological tolerance.Keywords
All Related Versions
Funding Information
- Morris Animal Foundation (D14ZO-410)
- Royal Hobart Hospital Research Foundation (Incubator Grant # F0026331)
- Australian Research Council (DE180100484)
- Australian Research Council (LP0989727)
- Australian Research Council (DP130100715)
- Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government (RC50680)
- Save the Tasmanian Devil Appeal (Eric Guiler 2013, 2015, 2017, 2018)
This publication has 47 references indexed in Scilit:
- Structures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and EvolutionStructure, 2013
- Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancerProceedings of the National Academy of Sciences, 2013
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4Science, 2011
- Mortality in North American Dogs from 1984 to 2004: An Investigation into Age-, Size-, and Breed-Related Causes of DeathJournal of Veterinary Internal Medicine, 2011
- The role of CD200 in immunity to B cell lymphomaJournal of Leukocyte Biology, 2010
- The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible CancerScience, 2010
- The Immunohistochemical Characterization of Devil Facial Tumor Disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii)Veterinary Pathology, 2006
- Clonal Origin and Evolution of a Transmissible CancerCell, 2006
- Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activationJournal of Leukocyte Biology, 2005
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004